We’re the plan to change the future type. JDRF research focuses on key therapies that hold significant promise in turning Type One into Type None, including: artificial pancreas, encapsulation, smart insulin, restoration, and prevention.
Linda Wright has been a teacher, a salesperson and manager in a marketing company, and now a chef and the owner of her own catering business. She says, “Volunteering with JDRF incorporates all those professions.”
Last year JDRF took a number of significant actions to broaden the resources available in the T1D research and development space – three of them are highlighted here. Each of these will help speed progress towards our research goals across our portfolio of research objectives to develop and deliver novel T1D therapies to patients. In […]
The holidays are upon us! No matter which celebration(s) you observe—Thanksgiving, Hanukkah, Christmas, Kwanzaa, New Year’s Eve, you name it—we’ve got a wealth of information from our archives to help you ring in your healthiest, happiest type 1 diabetes (T1D) holiday season yet.
A new JDRF-funded study will evaluate whether metformin—a drug commonly used to treat type 2 diabetes (T2D)—combined with standard insulin therapy could safely improve blood-glucose control in overweight children and adolescents with type 1 diabetes (T1D). For more than 50 years, metformin has proven safe and effective in helping to control blood-glucose levels in people […]
A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Type 1 diabetes (T1D) scientists have believed for some time that communities of bacterial microorganisms in the gut, which make up the microbiome, are in some way related to immune system defects and the autoimmune response that leads to T1D. Previous research has hypothesized that the diversity or abundance of specific bacteria within the microbiome […]
When Kevin Wehrenberg became concerned about the media’s portrayal of type 1 diabetes (T1D) during the nomination of Supreme Court Justice Sonia Sotomayor, he contacted the Los Angeles Chapter, wanting to discuss the issue. The chapter’s executive director was impressed and soon asked Kevin to join the local Board.
Step into the shoes of someone living with type 1 diabetes (T1D) for one day in an eye-opening text campaign made possible through the generous support of Lilly Diabetes. In just a single day, you’ll gain a deeper understanding of the challenges people with T1D face. Sign up today, or any day in November, and […]
JDRF is kicking off National Diabetes Awareness Month by turning the Empire State Building blue! On the evening of November 1—T1Day—New York’s iconic landmark will blaze blue to promote diabetes awareness and show support for the 366 million people worldwide living with both type 1 diabetes (T1D) and type 2 diabetes. Awareness for T1D doesn’t […]